top of page

Science &

We are i&i Biotech Fund (i&i Bio), partners of outstanding founders on their path to global success. 

About i&i bio

We invest in innovative early stage Life Sciences startups that address unmet needs with novel discoveries backed by strong science and competitive advantage over current options.

We like to partner with founders creating breakthrough businesses
in technology and healthcare. We are interested in start-ups with a unique selling point and global potential. 

our focus





ai in Life sciences


We are happy to help you start your business from the very beginning. 
It is never too early for us to meet you. We approach each project individually, but our preferred option is to act as co-investor. 


Ready to create? We can start at € 150 K to support business creation.

Series A

Ready to grow? Our sweet spot lies between € 0.5 M and € 2 M.

Series B

Being exceptional? We keep
a possibility of extra funding for our unicorn portfolio.

Where we invest 

 We focus mainly on Central and Eastern Europe. However, we are open to working with ambitious teams from other regions.

 We focus mainly on European Union members. However, we are open to working with ambitious teams from other regions.

what we offer


Our team is made up of Life Science and investment professionals with years of relevant experience. We work closely with our expert partners from i&i Prague and IOCB Tech. We are ready to help if needed.


We have a network of partners who evaluate and, in some cases, test technologies. We can provide valuable feedback or even confirmation of effectiveness by independent experts in the R&D field.


We value partnerships with our network of investors and potential exit partners. We believe that it is advantageous for start-ups to meet such partners at the beginning of their journey to success. We can open the door for you.

Our partners

our partners

Kopie eif web_edited.png

European Investment Fund

i&i Biotech fund is supported by an investment from the EIF, with the support of lnnovFin Equity, with the financial backing of the EU under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe (the purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing) and the Pan-European Guarantee Fund (EGF), implemented by the EIF with the financial support of the Participating Member States (the objective of EGF is to respond to the economic impact of the COVID-19 pandemic by ensuring that companies in the Participating Member States have sufficient short-term liquidity available to weather the crisis and are able to continue their growth and development in the medium to long-term).

uochb tech web.png


Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) is a leading research institution under the umbrella of the Czech Academy of Sciences. Their mission is basic research at the interface of chemical and biological sciences, and translation of results from basic research into applications and commercial assets.


Česká spořitelna

Česká spořitelna is the bank with the longest tradition in the Czech market, providing its services to individuals, small and medium-sized enterprises, towns and municipalities. However, it also finances large corporations and provides financial market services. Many of the bank's products and services are market leaders in the Czech Republic. Since 2000, it has been part of the strong Central European Erste Group.

cuip web_edited.png


Charles University Innovations Prague a.s. (CUIP) is a subsidiary of Charles University, which was founded on 22nd June 2018. Its goal is to encourage and facilitate transfer of knowledge and technology from academic research into daily life.


i&i pragUE

i&i Biotech Fund was born from i&i Prague. This bio-innovation centre specializes in the transfer of new technologies into practice. It was established as a subsidiary of the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, and primarily focuses on innovations in the areas of drug discovery, diagnostics, and medical devices developed by academic institutions. It supports the creation of spin-offs and the sale of licenses. Support of this bio-innovation centre consists in sourcing deals through i&i Prague’s own relationships with regional research and development organizations, identification of projects with great commercial potential, evaluation of projects, assistance with business setup, potential to invest in projects incubated by i&i Prague, with clear rules basically covering only incubation costs of i&i without any profit.

iocb tech_pruhledny ctverec.png

iocb tech

IOCB Tech is a technology transfer office and subsidiary company of Institute of Organic Chemistry and Biochemistry. The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.


Czech Academy of Sciences

The primary mission of the Czech Academy of Sciences and its institutes is to conduct research in a broad spectrum of the natural, technical and social sciences and the humanities. This research aims to advance developments in scientific knowledge at the international level, while also taking into account the specific needs of both Czech society and national culture. 




i&i Biotech Fund I SCSp
42, rue de la Vallée,
L-2661 Luxembourg
BP 908 L-2019, Luxembourg


+420 725 731 199


Investment Adviser

Biotech Investments, s. r. o.
Pobřežní 394/12,
186 00 Praha 8

Czech Republic

Social Media

  • LinkedIn - Black Circle
bottom of page